Volume : XI, Issue : VII, July - 2022
Bamlanivimab as monotherapy for high-risk COVID-19 patients with mild to moderate symptoms
Kathryn Fivelstad, Tuong Pham, Kristen Meacham, Alberto Hazan, Patrick Olivieri, Michael Doctor
Abstract :
Keywords :
Article:
Download PDF
DOI : 10.36106/ijsr/9423817
Cite This Article:
BAMLANIVIMAB AS MONOTHERAPY FOR HIGH-RISK COVID-19 PATIENTS WITH MILD TO MODERATE SYMPTOMS, Kathryn Fivelstad, Tuong Pham, Kristen Meacham, Alberto Hazan, Patrick Olivieri, Michael Doctor INTERNATIONAL JOURNAL OF SCIENTIFIC RESEARCH : Volume-11 | Issue-7 | July-2022
Number of Downloads : 49
References :
BAMLANIVIMAB AS MONOTHERAPY FOR HIGH-RISK COVID-19 PATIENTS WITH MILD TO MODERATE SYMPTOMS, Kathryn Fivelstad, Tuong Pham, Kristen Meacham, Alberto Hazan, Patrick Olivieri, Michael Doctor INTERNATIONAL JOURNAL OF SCIENTIFIC RESEARCH : Volume-11 | Issue-7 | July-2022
Our Other Journals...
-
Indian Journal of
Applied Research Visit Website -
PARIPEX Indian Journal
of Research Visit Website -
Global Journal for
Research Analysis Visit Website